Life-saving opioid antidote accessible to only 2 pc patients, finds study

A COVID-19 diagnosis is no longer as frightening as it used to be, thanks to developments in treatment choices. However, a new study reveals that leukocyte (white blood cell) count may now be used to identify who is more likely to develop more significant disease symptoms.

A study by Van Andel Institute scientists suggests that restricting cancer cells' access to fat may enhance the effectiveness of certain cancer treatments.

The matter of what causes complicated neurological disorders like Alzheimer's or multiple sclerosis continues to perplex scientists and doctors, with unknowns impeding early diagnosis and successful treatment.

Columbia researchers developed probiotic bacteria that train the immune system to eliminate cancer cells, paving the way for a new class of cancer vaccinations that take advantage of bacteria's innate tumour-targeting abilities. These microbial cancer vaccines can be tailored to each person's specific original tumour and metastases, perhaps preventing future recurrences.

Researchers at Colorado State University discovered an alternative way for studying alterations during the DNA replication process in lab settings using genetically modified yeast. The novel methodology provides a clearer picture than current pharmacological methods for understanding cell cycle arrest, a fundamental mechanism critical to cancer treatment and genetic concerns.

The significance of gamma-delta T cells in 33 different cancer types is revealed in a recent study that was published in Cell Press. This information sheds light on the cells' potential as clinical biomarkers and therapeutic targets in the treatment of cancer. This thorough examination, which was carried out under the direction of a group of Moffitt Cancer Center experts, marks a substantial breakthrough in our knowledge of these distinct immune cells and how they affect cancer therapy outcomes for patients.

A recent study by researchers at the University of Arizona College of Medicine - Phoenix and the University of California Davis Health discovered a new target for developing a medication to treat atrial fibrillation, the most prevalent kind of irregular heart rhythm.

Approximately 20 per cent of women, who have recurrent pregnancy loss, test positive for a particular antibody that attacks the mother's own body.

When researchers discovered enough proof that a medication used to treat bone marrow cancer and Kaposi sarcoma is safe and effective in treating hereditary hemorrhagic telangiectasia (HHT), a rare bleeding disorder that affects 1 in 5,000 people worldwide, they decided to terminate an early clinical trial funded by the National Institutes of Health

Researchers have identified thousands of genetic variants in a gene that could raise an individual's risk of ovarian and breast cancer, opening the door to more accurate risk assessment and individualised treatment.